Cutaneous leishmaniasis (CL) in mice has been shown to produce hyperalgesia and upregulation of interleukin (IL)-1β and nerve growth factor (NGF) levels. The aim of this study was to investigate the effects of thymulin on CL-induced hyperalgesia and cytokine upregulation. Daily treatment with thymulin (1, 100, and 1000 ng/ip) produced dose-dependent decreases in CL-induced hyperalgesia as assessed by the tail flick and the hot plate tests. The levels of NGF and IL-1β were determined in the skin tissues of the hind leg in different groups (n ϭ 5 each) of mice over a period of 5 weeks. Mice with CL showed sustained increase in the levels of IL-1β and NGF which were reversed by thymulin (1 µg). Injection of thymulin only did not alter the nociceptive thresholds or the levels of IL-1β and NGF. We conclude that thymulin can modulate the hyperalgesia induced by CL by decreasing the levels of the proinflammatory factors IL-1β and NGF. © 2001 Elsevier Science (USA)
INTRODUCTION
Traditional description of cutaneous leishmaniasis (CL) does not include syndromes related to neural involvement by this skin disease (Magill, 1995) . Furthermore, despite the evident skin ulceration and the well-documented upregulation of proinflammatory cytokines such as interleukins (IL)-1β and interferon-δ (for review, see Liew & O'Donnell, 1993; Bogdan & Röllinghoff, 1998) , disturbed somatic sensations have been rarely included in the clinical description of CL (Grevelink & Lerner, 1996) . In addition, hyperalgesia, hypersthesia, and analgesia have been often used as helpful signs for the discrimination between leprosy and leishmaniasis (Kubba et al., 1987) . Few clinical reports, however, have described a possible neural involvement in patients with CL (Kubba et al., 1987; Satti et al., 1989; Kibbi et al., 1996) .
More recently, we reported evident hyperalgesia with significant upregulation of IL-1β and nerve growth factor (NGF) in a murine model of CL induced by Leishmania major (Kanaan et al., 2000) . The hyperalgesia in this murine model was observed before the appearance of skin lesions and correlated with the increased levels of IL-1β and NGF. The latter factors have both been shown to be increased during inflammation (Dray & Bevan, 1993; Ferreira et al., 1993) and to contribute to the resulting hyperalgesia (Ferreira et al., 1988; Maier et al., 1993; Safieh-Garabedian et al., 1995) . Furthermore, IL-1β and NGF have been considered important indicators
